Toggle light / dark theme

In a new letter, Elon Musk threatens to walk away from $44 Billion Twitter deal if the management doesn’t provide more data on total bot counts.

According to a letter sent by Elon Musk’s legal team to Twitter, “Twitter refused to provide the information that Mr. Musk has repeatedly requested since May 9, 2022 to facilitate his evaluation of spam and fake accounts on the company’s platform” and “It’s effort to characterize it otherwise is merely an attempt to obfuscate and confuse the issue”.

The letter also reminded that Musk does not believe the company’s lax testing methodologies are adequate so he must conduct his own analysis and “The data he has requested is necessary to do so”. The letter also said “Mr. Musk is entitled to seek, and Twitter is obligated to provide information and data”.

A group of photonics researchers at Tampere University have introduced a novel method to control a light beam with another beam through a unique plasmonic metasurface in a linear medium at ultra-low power. This simple linear switching method makes nanophotonic devices such as optical computing and communication systems more sustainable, requiring low intensity of light.

A group of photonics researchers at Tampere University have introduced a novel method to control a light beam with another beam through a unique plasmonic metasurface in a linear medium at ultra-low power. This simple linear switching method makes nanophotonic devices such as optical computing and communication systems more sustainable, requiring low intensity of light.

All– is the modulation of signal light due to control light in such a way that it possesses the on/off conversion function. In general, a can be modulated with another intense laser beam in the presence of a nonlinear medium.

The switching method developed by the researchers is fundamentally based on the quantum optical phenomenon known as Enhancement of Index of Refraction (EIR).

Elon Musk accused Twitter of “resisting and thwarting” his right to information about fake accounts on the platform, calling it in a letter to the company on Monday a “clear material breach” of the terms of their merger agreement.

“Mr. Musk reserves all rights resulting therefrom, including his right not to consummate the transaction and his right to terminate the merger agreement,” the letter, signed by Skadden Arps attorney Mike Ringler, says.

Twitter shares were down 5% on Monday morning.

A drug combination targeting multiple mutant versions of cancer’s “death star” protein has shown promise in a small, early-phase clinical trial for some patients with advanced lung, ovarian and thyroid cancer.

The two– was effective against with a range of mutations to the KRAS gene—dubbed the “death star” because its protein drives one in four cancers and has a largely impenetrable, drug-resistant surface.

The phase I trial tested the drugs VS-6766 and everolimus in 30 patients with a range of mutations to KRAS—including 11 with highly advanced, .